Related Experiment Video
Updated: Jun 8, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
Tamara Terzian1, Enrique C Torchia, Daisy Dai
1Department of Dermatology and Charles C Gates Center for Regenerative Medicine and Stem Cell Biology, UC Denver, Aurora, CO 80045, USA.
Abstract:
p53 is the central member of a critical tumor suppressor pathway in virtually all tumor types, where it is silenced mainly by missense mutations. In melanoma, p53 predominantly remains wild type, thus its role has been neglected. To study the effect of p53 on melanocyte function and melanomagenesis, we crossed the ‘high-p53’Mdm4+/− mouse to the well-established TP-ras0/+ murine melanoma progression model. After treatment with the carcinogen dimethylbenzanthracene (DMBA), TP-ras0/+ mice on the Mdm4+/− background developed fewer tumors with a delay in the age of onset of melanomas compared to TP-ras0/+ mice. Furthermore, we observed a dramatic decrease in tumor growth, lack of metastasis with increased survival of TP-ras0/+: Mdm4+/− mice. Thus, p53 effectively prevented the conversion of small benign tumors to malignant and metastatic melanoma. p53 activation in cultured primary melanocyte and melanoma cell lines using Nutlin-3, a specific Mdm2 antagonist, supported these findings. Moreover, global gene expression and network analysis of Nutlin-3-treated primary human melanocytes indicated that cell cycle regulation through the p21WAF1/CIP1 signaling network may be the key anti-melanomagenic activity of p53.
Insights
The tumor suppressor p53 protein significantly inhibits melanoma development and metastasis. Enhancing p53 activity in mice reduced tumor growth and increased survival, highlighting its anti-melanoma potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 protein is a crucial tumor suppressor, often inactivated in cancers.
- In melanoma, p53 typically remains functional, yet its role in melanomagenesis is understudied.
Purpose of the Study:
- To investigate the impact of p53 on melanocyte function and melanoma development.
- To explore p53's potential as a therapeutic target in melanoma.
Main Methods:
- Utilized a genetically modified mouse model (Mdm4+/−) crossed with a murine melanoma progression model (TP-ras0/+).
- Administered the carcinogen dimethylbenzanthracene (DMBA) to induce melanoma.
- Activated p53 in cell lines using Nutlin-3, an Mdm2 antagonist.
- Performed global gene expression and network analysis on treated human melanocytes.
Main Results:
- Mice with enhanced p53 activity (TP-ras0/+: Mdm4+/−) exhibited delayed melanoma onset, reduced tumor incidence, and decreased tumor growth.
- These mice showed a notable lack of metastasis and increased survival rates.
- Nutlin-3 treatment activated p53 and supported these anti-melanoma effects in cell culture.
- Gene expression analysis suggested p53's anti-melanomagenic effects are mediated by cell cycle regulation via the p21WAF1/CIP1 pathway.
Conclusions:
- p53 plays a significant role in preventing the progression of benign tumors to malignant and metastatic melanoma.
- Targeting p53, potentially through Mdm2 inhibition, represents a promising therapeutic strategy for melanoma.
- Cell cycle regulation by p53 is a key mechanism underlying its tumor-suppressive function in melanoma.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

